Neurocrine Biosciences | NBIX - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
AbbVie USD 508.97B 46.71B 2026-11
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
ALKERMES USD 7.39B 595M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.95B 667M 2026-11
Cytokinetics USD 7.51B 1.66B 2026-11
Enanta Pharmaceuticals USD 122M 98M 2024-12
Exelixis USD 19.82B 5.34B 2026-11
Gilead Sciences USD 184.82B 27.96B 2026-09
Halozyme Therapeutics USD 15.62B 3.09B 2026-11
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 14.46B 45M 2026-11
Pfizer USD 169.88B 6.47B 2026-11
Prothena USD 437M 76M 2026-11
Repligen USD 9.74B 1.1B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
Teva Pharmaceutical Industries USD 152.12B 105.39B 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11